JP2021525266A5 - - Google Patents
Info
- Publication number
- JP2021525266A5 JP2021525266A5 JP2020565864A JP2020565864A JP2021525266A5 JP 2021525266 A5 JP2021525266 A5 JP 2021525266A5 JP 2020565864 A JP2020565864 A JP 2020565864A JP 2020565864 A JP2020565864 A JP 2020565864A JP 2021525266 A5 JP2021525266 A5 JP 2021525266A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- composition
- lopinavir
- ritonavir
- hpv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1808564.7 | 2018-05-24 | ||
| GBGB1808564.7A GB201808564D0 (en) | 2018-05-24 | 2018-05-24 | Treatments |
| PCT/IB2019/054292 WO2019224779A1 (en) | 2018-05-24 | 2019-05-23 | Lopinavir and ritonavir for the treatment of cervix disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021525266A JP2021525266A (ja) | 2021-09-24 |
| JP2021525266A5 true JP2021525266A5 (https=) | 2023-07-19 |
| JP7344911B2 JP7344911B2 (ja) | 2023-09-14 |
Family
ID=62812406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020565864A Active JP7344911B2 (ja) | 2018-05-24 | 2019-05-23 | 頸部障害の処置のためのロピナビルおよびリトナビル |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11738024B2 (https=) |
| EP (1) | EP3801509A1 (https=) |
| JP (1) | JP7344911B2 (https=) |
| CN (1) | CN112203656B (https=) |
| AU (1) | AU2019274812B2 (https=) |
| BR (1) | BR112020023964A2 (https=) |
| CA (1) | CA3100425A1 (https=) |
| GB (1) | GB201808564D0 (https=) |
| MX (1) | MX2020012656A (https=) |
| SG (1) | SG11202010138WA (https=) |
| WO (1) | WO2019224779A1 (https=) |
| ZA (1) | ZA202006324B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201808563D0 (en) | 2018-05-24 | 2018-07-11 | Univ Manchester | Treatments |
| GB201808564D0 (en) | 2018-05-24 | 2018-07-11 | Douglas Pharmaceuticals Ltd | Treatments |
| GB201907305D0 (en) | 2019-05-23 | 2019-07-10 | Douglas Pharmaceuticals Ltd | Treatment of conditions |
| GB201917252D0 (en) * | 2019-11-27 | 2020-01-08 | Pharmaceutic compositions |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8822857D0 (en) | 1988-09-29 | 1988-11-02 | Patralan Ltd | Pharmaceutical formulations |
| TR201809435T4 (tr) | 2000-01-19 | 2018-07-23 | Abbvie Inc | Geliştirilmiş farmasötik formülasyonlar. |
| TWI231211B (en) | 2001-05-01 | 2005-04-21 | Abbott Lab | Compositions and methods for enhancing the bioavailability of pharmaceutical agents |
| US20030129208A1 (en) | 2002-01-07 | 2003-07-10 | Alberts David S. | Topical application of alpha-DFMO and anti-inflammatory drug for treatment of actinic keratoses |
| WO2004010937A2 (en) | 2002-07-26 | 2004-02-05 | Advanced Research & Technology Institute At Indiana University | Method of treating cancer |
| BR0302523A (pt) | 2003-07-23 | 2005-04-05 | Cristalia Prod Quimicos Farm | Composição farmacêutica estável para administração de inibidores da hiv protease e processo de obtenção de composição farmacêutica concentrada para a administração de inibidores da hiv protease |
| US8377952B2 (en) | 2003-08-28 | 2013-02-19 | Abbott Laboratories | Solid pharmaceutical dosage formulation |
| WO2005053694A1 (en) | 2003-11-28 | 2005-06-16 | The University Of Manchester | Treatment of hpv infections and cancer |
| WO2008088806A1 (en) | 2007-01-16 | 2008-07-24 | Johns Hopkins University | Combinational paradigm combating hiv, hiv/hsv, or hiv/hpv infections in humans using small molecular weight compounds from plants |
| WO2009129470A2 (en) | 2008-04-18 | 2009-10-22 | Nanobio Corporation | Methods for treating herpes virus infections |
| GB201006038D0 (en) | 2010-04-12 | 2010-05-26 | Unilever Plc | Improvements relating to antiviral compositions |
| US20140004186A1 (en) | 2010-09-08 | 2014-01-02 | Pronova Biopharma Norge As | Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin |
| GB201115635D0 (en) * | 2011-09-09 | 2011-10-26 | Univ Liverpool | Compositions of lopinavir and ritonavir |
| AU2014338707B2 (en) | 2013-10-23 | 2020-06-04 | The University Of Manchester | Treatment of cancer and benign proliferative disorders |
| WO2016123541A2 (en) | 2015-01-30 | 2016-08-04 | Tobira Therapeutics, Inc. | Cenicriviroc for the treatment of encephalitis infection |
| WO2019130341A1 (en) | 2017-12-26 | 2019-07-04 | Hetero Labs Limited | Capsule compositions comprising lopinavir and ritonavir |
| GB201808564D0 (en) | 2018-05-24 | 2018-07-11 | Douglas Pharmaceuticals Ltd | Treatments |
| GB201808571D0 (en) | 2018-05-24 | 2018-07-11 | Douglas Pharmaceuticals Ltd | Pharmaceutical compositions |
| GB201808563D0 (en) | 2018-05-24 | 2018-07-11 | Univ Manchester | Treatments |
| GB201808567D0 (en) | 2018-05-24 | 2018-07-11 | Douglas Pharmaceuticals Ltd | Pharmaceutical compositions |
| GB201907305D0 (en) | 2019-05-23 | 2019-07-10 | Douglas Pharmaceuticals Ltd | Treatment of conditions |
| GB201917252D0 (en) | 2019-11-27 | 2020-01-08 | Pharmaceutic compositions |
-
2018
- 2018-05-24 GB GBGB1808564.7A patent/GB201808564D0/en not_active Ceased
-
2019
- 2019-05-23 EP EP19732473.4A patent/EP3801509A1/en active Pending
- 2019-05-23 CA CA3100425A patent/CA3100425A1/en active Pending
- 2019-05-23 MX MX2020012656A patent/MX2020012656A/es unknown
- 2019-05-23 AU AU2019274812A patent/AU2019274812B2/en active Active
- 2019-05-23 JP JP2020565864A patent/JP7344911B2/ja active Active
- 2019-05-23 WO PCT/IB2019/054292 patent/WO2019224779A1/en not_active Ceased
- 2019-05-23 SG SG11202010138WA patent/SG11202010138WA/en unknown
- 2019-05-23 BR BR112020023964-0A patent/BR112020023964A2/pt unknown
- 2019-05-23 CN CN201980034993.5A patent/CN112203656B/zh active Active
- 2019-05-23 US US17/055,048 patent/US11738024B2/en active Active
-
2020
- 2020-10-12 ZA ZA2020/06324A patent/ZA202006324B/en unknown
-
2023
- 2023-06-30 US US18/216,937 patent/US20240148729A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021525266A5 (https=) | ||
| US10543228B2 (en) | Pharmaceutical preparation containing selenite or selenite-containing compounds for treating cervical dysplasia or carcinomas | |
| US20240148729A1 (en) | Lopinavir and ritonavir for the treatment of cervix disorders | |
| CN101181636B (zh) | 一种防治人乳头瘤病毒感染的复方疫苗组合物、复方疫苗阴道喷雾剂及其用途 | |
| Mudrikova et al. | HPV-related anogenital disease and HIV infection: not always ‘ordinary’condylomata acuminata | |
| CA2445506C (en) | Use of sucralfate for the treatment of cervical erosion | |
| Savoca et al. | CO 2 laser vaporization as primary therapy for human papillomavirus lesions: A prospective observational study | |
| CN114053475A (zh) | 一种抗hpv医用妇科敷料 | |
| JP2021536454A5 (https=) | ||
| MA53482B1 (fr) | Thérapie d'infections par le papillomavirus humain à haut risque | |
| DeRossi et al. | The management of oral human papillomavirus with topical cidofovir: a case report | |
| Afshar et al. | Clinical and Public Health Considerations for HPV Infection in Men: A Narrative Review | |
| Mohseni Afshar et al. | Clinical and public health considerations for hpv infection in men: A narrative review | |
| CA2841851A1 (en) | Composition and method for treating hpv | |
| EP4046646A1 (en) | Pharmaceutical composition for the treatment of hpv infections | |
| RU2747987C1 (ru) | Композиция для лечения латентной и субклинической папилломавирусной инфекции шейки матки и способ ее применения | |
| Bannerjee | Anogenital Warts | |
| Pils et al. | HPV-associated Dysplasia of Skin and Mucosa and Vaccination Options in Trans People | |
| Condic et al. | Severe Leukoplakia of the Vagina and Cervix Successfully Treated with Intravaginal Application of Topical Glucocorticoids | |
| Conageski | A 25-Year-Old Woman with LSIL Desiring HPV Vaccination | |
| Qadri et al. | Progress in the Treatment of Infantile Hemangioma | |
| JP2023516153A5 (https=) | ||
| HK1243360B (zh) | 用於治疗子宫颈非典型性增生或子宫颈癌的包含亚硒酸盐或含亚硒酸盐化合物的药物制剂 | |
| TRANSMITTED | CONDYLOMATA ACUMINATA | |
| CN101267812A (zh) | 治疗皮肤病变的腙药剂 |